Titolo	Data di pubblicazione	Autore(i)
1	Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study.	2012	Scagliotti GV; Kosmidis P; de Marinis F; Schreurs AJ; Albert I; Engel-Riedel W; Schallier D; Barbera S; Kuo HP; Sallo V; Perez JR; Manegold C.
2	Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5	Being printed	Milosevic V.; Kopecka J.; Salaroglio I.C.; Libener R.; Napoli F.; Izzo S.; Orecchia S.; Ananthanarayanan P.; Bironzo P.; Grosso F.; Tabbo F.; Comunanza V.; Alexa-Stratulat T.; Bussolino F.; Righi L.; Novello S.; Scagliotti G.V.; Riganti C.
3	Which should be added to cisplatin for advanced non-small-cell lung cancer--vinorelbine or gemcitabine?	2005	SCAGLIOTTI GV
4	The way forward: new drugs and new therapeutic strategies in lung cancer therapy.	2006	SCAGLIOTTI GV ;NOVELLO S
5	Updated clinical information on multitargeted antifolates in lung cancer	2009	Scagliotti G.V.; Ceppi P.; Capelletto E.; Novello S.
6	Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy	2018	Shukla, Navika D.; Salahudeen, Ameen A.; Taylor, Gregory A.; Ramalingam, Suresh S.; Vokes, Everett E.; Goss, Glenwood D.; Decker, Roy H.; Kelly, Karen; Scagliotti, Giorgio V.; Mok, Tony S.; Wakelee, Heather A.*
7	Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: A case report and review of the literature	2015	Brizzi, Maria Pia; Sonetto, Cristina; Tampellini, Marco; Di Maio, Massimo; Volante, Marco; Scagliotti, Giorgio V.
8	Unresectable non-small cell lung cancer chemotherapy with high-dose cisplatin and etoposide.	1985	SCAGLIOTTI GV ;LODICO D ;GOZZELINO F ;BARDESSONO F ;ALBERA C ;GATTI E ;PESCETTI G
9	Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.	2014	Rondón-Lagos M;Verdun Di Cantogno L;Rangel N;Mele T;Ramírez-Clavijo SR;Scagliotti G;Marchiò C;Sapino A
10	Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer	2015	Buttigliero, Consuelo; Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Bironzo, Paolo; Di Maio, Massimo; Scagliotti, Giorgio Vittorio
11	[Ultrastructure of the pulmonary alveolus. Correlations with the endoalveolar tensioactive system]	1980	Pescetti, G; Gozzelino, F; Osella, D; Scagliotti, G
12	Tyrosine kinase signal transduction inhibitors. Clinical trials	2002	Scagliotti, Giorgio Vittorio
13	Tumor/Stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis	2014	Righi, L; Cavallo, Mc; Gatti, G; Monica, V; Rapa, I; Busso, S; Albera, C; Volante, M; Scagliotti, Gv; Papotti, M.
14	Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer.	2011	Scagliotti G; Brodowicz T; Shepherd FA; Zielinski C; Vansteenkiste J; Manegold C; Simms L; Fossella F; Sugarman K; Belani CP.
15	Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit	2017	Tampellini, Marco; Di Maio, Massimo; Baratelli, Chiara; Anania, Lorenzo; Brizzi, Maria Pia; Sonetto, Cristina; La Salvia, Anna; Scagliotti, Giorgio Vittorio
16	Treatment of advanced non-small cell lung cancer.	2006	DE PETRIS L ;CRINÒ L ;SCAGLIOTTI GV ;GRIDELLI C ;GALETTA D ;METRO G ;NOVELLO S ;MAIONE P ;COLUCCI G ;DE MARINIS F
17	Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.	2003	ROSELL R; G. SCAGLIOTTI; DANENBERG KD; LORD RVN; BEPLER G; NOVELLO S; COOC J; CRIN L; SANCHEZ JJ; TARON M; BONI C; DE MARINIS F; TONATO M; MARANGOLO M; GOZZELINO F; DI COSTANZO F; RINALDI M; SALONGA D; STEPHENS C
18	Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.	2001	Dingemans AC; van Ark-Otte J; Span S; Scagliotti GV; van der Valk P; Postmus PE; Giaccone G.
19	Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer	2017	Roca, Elisa; Berruti, Alfredo; Sbiera, Silviu; Rapa, Ida; Oneda, Ester; Sperone, Paola; Ronchi, Cristina L; Ferrari, Laura; Grisanti, Salvatore; Germano, Antonina; Zaggia, Barbara; Scagliotti, Giorgio Vittorio; Fassnacht, Martin; Volante, Marco; Terzolo, Massimo; Papotti, Mauro
20	Tnp-alpha determination in serum and pleural effusion in patients with lung-cancer	1995	Scagliotti, G; Gatti, E; Ferrari, G; Mutti, L; Pozzi, E